Stock Quote

GlaxoSmithKline PLC (GSK.L) (London Stock Exchange)
As of  23 Nov 2009
1,277.50GBp
Price Change
+24.00
Percent Change
+1.91%
 
1,277.50p
23 Nov 2009
+1.91%
1,253.50p
1,262.00p
8,848,114
1,286.00p
1,259.00p
1,319.00p
982.00p
0.43
8,221,007

Research Another Stock: Symbol Look-up
Healthcare Stocks: Safe and Speculative
12:56pm EST(The Street) 
China Biotech Week in Review: CROs Consolidating
Sunday, 22 Nov 2009 08:03am EST(Seeking Alpha) 
GlaxoSmithKline Takes 'Three-Pronged' Approach in China to Fight H1N1 Flu
Sunday, 22 Nov 2009 07:50am EST(Seeking Alpha) 
4-Star Stocks Poised to Pop: Merck
Friday, 20 Nov 2009 04:51am EST(The Motley Fool) 
'Fast Money' Recap: Playing Defense
Thursday, 19 Nov 2009 07:46pm EST(The Street) 
 
Name Current Position Compensation
Gent, Christopher Non-Executive Chairman of the Board 651,000
Witty, Andrew Chief Executive Officer, Executive Director 1,778,000
Heslop, Julian Chief Financial Officer, Executive Director 926,000

Profile

GlaxoSmithKline plc (GSK) is a global healthcare group, which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK’s principal pharmaceutical... Full Description

Company Address

GlaxoSmithKline PLC
980 Great West Road
Brentford
Middlesex   ENG   TW8 9GS
P: +4420.80475000
F: +4420.80477807

Analyst Research

  GSK.L Industry
P/E(TTM) 13.10 6.90
P/S(TTM) 2.39 1.54
ROI(TTM) 18.34 6.18
ROE(TTM) 58.25 9.32
Consensus Recommendation Outperform
EPS Est. (Current Period) 27.80
EPS Est. (Current Year) 120.50
Total Revenue $6,758.00M
Net Income $1,371.00M
EPS $0.26